Clinical Trials in Seattle

Showing 2161-2180 of 9,312 trials

ADAPT Study: Assessing Diet, Appetite and Physiology Throughout Weight Loss Study)

NCT06174389

Behavioral weight loss programs for obesity can result in weight loss and health benefits. However, behavioral weight loss often stops despite efforts to continue losing weight, this can be called an involuntarily weight loss plateau. This study investigates changes in metabolism and/or the brain that contribute to the occurrence of an involuntary weight loss plateau.

Obesity

University of Washington90 participantsStarted Oct 2023

Seattle, Washington, United States • Seattle, Washington, United States

COMPLETED< 1 mile

Post-approval Study of New Enrolment Patients Undergoing Bilateral Treatment With the VisuMax SMILE Procedure

NCT05740293

The objective of the post-approval study (PAS) is to assess patient experience of visual symptoms 6 months after bilateral treatment with the VisuMax SMILE procedure as measured by a patient questionnaire.

MyopiaAstigmatism

Carl Zeiss Meditec, Inc.186 participantsStarted Apr 2022

Fayetteville, Arkansas, United States • Rowland Heights, California, United States • Leawood, Kansas, United States +4 more locations

Active Not RecruitingPhase 3< 1 mile

A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

NCT04437511

The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease. Additional participants will be enrolled to an addendum safety cohort. The participants will be administered open-label donanemab. Trial participants who were dosed with donanemab in the main study will be enrolled to a 3-year follow up addendum. No study drug will be administered during this follow up.

Alzheimer Disease

Eli Lilly and Company1,736 participantsStarted Jun 2020

Gilbert, Arizona, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +271 more locations

ADAPT Study: Assessing Diet, Appetite and Physiology Throughout Weight Loss Study)

Post-approval Study of New Enrolment Patients Undergoing Bilateral Treatment With the VisuMax SMILE Procedure

A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

Find Trials by Condition in Seattle

Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma

Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866/KEYNOTE-866)

A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome

Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes

Acalabrutinib, Obinutuzumab and Chlorambucil in Treatment naïve CLL

The Diabetes Prevention Program Outcomes Study AD/ADRD Project

Clinical and Basic Investigations Into Congenital Disorders of Glycosylation

Study of Safety and Effectiveness of the Boston Orthokeratology Shaping Lens in the Arise Orthokeratology Lens

A Study of LY3549492 in Healthy Weight Adult Participants

Mitral Valve Screening Survey

A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction

Psilocybin-Assisted Therapy for Treatment-Resistant Depression in Bipolar II Disorder

Long-Term Evaluation of BIIB067 (Tofersen)

A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha (FRα) Expression

Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T

A Stepped-Wedge Cluster Randomized Trial of a Digital App to Support Medication-Assisted Treatment in Individuals With Opioid Use Disorder

Effect of Evolocumab on Saphenous Vein Graft Patency Following Coronary Artery Bypass Surgery